DUSSELDORF, Germany – In the autumn of 2020, innovative diagnostic solutions were at the absolute forefront of the global response to the pandemic.
To safely and effectively meet these unprecedented challenges, Europe’s largest international partnering conference for diagnostics, digital health, regenerative medicine, and research tools had to pivot fast.
While originally planned as a hybrid event, rapidly increasing global restrictions forced a bold decision: DxPx 2020 completely adapted its concept, expanding into a fully digital, five-day partnering marathon from November 17th to 21st.
The strategy paid off, attracting over 150 elite investors and more than 350 registrants from over 20 countries who gathered virtually to evaluate critical investment opportunities, M&A options, licensing deals, and R&D partnerships.
